Biolase, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
9.50
|
|
Average Rating
|
4.75
|
|
# Strong Buys
|
3
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.84
|
-1.10
|
-0.26
|
-30.95%
|
|
2022-06-30
|
-0.62
|
-0.91
|
-0.29
|
-46.77%
|
|
2022-03-31
|
-0.68
|
-0.81
|
-0.13
|
-19.12%
|
|
2021-12-31
|
-0.62
|
-0.75
|
-0.13
|
-20.97%
|
|
2021-09-30
|
-0.69
|
-0.50
|
0.19
|
27.54%
|
|
2021-06-30
|
-1.08
|
-0.02
|
1.06
|
98.00%
|
|
2021-03-31
|
-1.25
|
-1.50
|
-0.25
|
-20.00%
|
|
2020-12-31
|
-0.92
|
-1.75
|
-0.83
|
-90.22%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.82
|
|
2021-12-31
|
-2.77
|
|
2020-12-31
|
-14.75
|
|
2019-12-31
|
-0.45
|
|
2018-12-31
|
-0.72
|
|
2017-12-31
|
-0.95
|
|
2016-12-31
|
-1.07
|
|
2015-12-31
|
-0.82
|
|
2014-12-31
|
-1.66
|
|
2013-12-31
|
-1.72
|
|
2012-12-31
|
-0.29
|
|
2011-12-31
|
-0.71
|
|
2010-12-31
|
-2.25
|
|
2009-12-31
|
-21.79
|
|
2008-12-31
|
-1.74
|
|
2007-12-31
|
-1.42
|
|
2006-12-31
|
-0.92
|
|
2005-12-31
|
-6.94
|
|
2004-12-31
|
-119.39
|
|
2003-12-31
|
1.57
|
|
2002-12-31
|
0.60
|
|
2001-12-31
|
-0.09
|
|
2000-12-31
|
-0.88
|
|
1999-12-31
|
-26.79
|